Literature DB >> 6235204

Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).

A Borghi, C Coronelli, L Faniuolo, G Allievi, R Pallanza, G G Gallo.   

Abstract

Teichomycin (teicoplanin) was found to be a mixture of five closely related components of similar polarity, designated T-A2-1, 2, 3, 4 and 5 and of one more polar component, designated T-A3. The separation of the single components was achieved by reverse phase partition chromatography and their physico-chemical and biological properties were compared. The results show that 1) the five major components have the same molecular size of about 1,900; 2) they contain the same ionization function, i.e., a carboxyl group and an amino group which form a zwitterion, and four phenolic groups; 3) they differ in a side aliphatic chain. The component T-A3 is not described.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235204     DOI: 10.7164/antibiotics.37.615

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  24 in total

1.  Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections.

Authors:  M Berti; G Candiani; M Borgonovi; P Landini; F Ripamonti; R Scotti; L Cavenaghi; M Denaro; B P Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Determination of sodium and chloride ions in teicoplanin lyophilized vials by nonsuppressed, single-column ion chromatography.

Authors:  M A de Soto-Perera
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

3.  Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.

Authors:  S Somma; L Gastaldo; A Corti
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

4.  Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell-wall peptides.

Authors:  P Arriaga; J Laynez; M Menendez; J Cañada; F Garcia-Blanco
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

Review 5.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

6.  Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

7.  Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography.

Authors:  B Joos; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

8.  Teicoplanin metabolism in rats.

Authors:  L F Zerilli; L Cavenaghi; A Bernareggi; A Assandri
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

9.  Pharmacokinetics of teicoplanin in renal failure.

Authors:  C Falcoz; N Ferry; N Pozet; G Cuisinaud; P Y Zech; J Sassard
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

10.  Teicoplanin pharmacokinetics in patients with chronic renal failure.

Authors:  M Bonati; G L Traina; G Villa; A Salvadeo; M G Gentile; G Fellin; R Rosina; L Cavenaghi; G Buniva
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.